Literature DB >> 9925364

Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy.

J R Schoenfeld1, M Vasser, P Jhurani, P Ng, J J Hunter, J Ross, K R Chien, D G Lowe.   

Abstract

The onset of cardiac hypertrophy is associated with characteristic changes in myocardial gene expression that are thought to recapitulate a developmental gene program. We report here the first gene expression profile of the murine myocardium, using a rapid method of quantitative expression analysis based on real-time analytical RT-PCR. This assay was used to measure expression levels of 29 genes in (1) late stage development as represented by day 1 neonatal ventricles, (2) normal cardiac growth in 3 and 18 month old mice, and (3) cardiac hypertrophy following pressure overload by aortic constriction. For males and females normal growth is not associated with differential expression although there is elevated expression of skeletal and smooth muscle actin mRNA's in males compared to females. Using normal adult ventricles as a reference, there are many qualitative and quantitative differences between the day 1 neonatal myocardium and experimental cardiac hypertrophy. These data suggest that the response to POL involves a subset of re-expressed developmental genes together with altered expression of genes not necessarily associated with cardiac development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925364     DOI: 10.1006/jmcc.1998.0787

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  24 in total

1.  Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.

Authors:  Stacey L House; Brian E House; Betty Glascock; Thomas Kimball; Eyad Nusayr; Jo El J Schultz; Thomas Doetschman
Journal:  Mol Cell Pharmacol       Date:  2010

2.  Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate.

Authors:  Lymari López-Díaz; Renu N Jain; Theresa M Keeley; Kelli L VanDussen; Cynthia S Brunkan; Deborah L Gumucio; Linda C Samuelson
Journal:  Dev Biol       Date:  2007-07-24       Impact factor: 3.582

3.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

4.  Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.

Authors:  J E Schultz; S A Witt; M L Nieman; P J Reiser; S J Engle; M Zhou; S A Pawlowski; J N Lorenz; T R Kimball; T Doetschman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.

Authors:  Eun Young Kim; Li Chen; Yanlin Ma; Wei Yu; Jiang Chang; Ivan P Moskowitz; Jun Wang
Journal:  J Mol Cell Cardiol       Date:  2011-12-01       Impact factor: 5.000

6.  Low-dose dasatinib rescues cardiac function in Noonan syndrome.

Authors:  Jae-Sung Yi; Yan Huang; Andrea T Kwaczala; Ivana Y Kuo; Barbara E Ehrlich; Stuart G Campbell; Frank J Giordano; Anton M Bennett
Journal:  JCI Insight       Date:  2016-12-08

7.  Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.

Authors:  Janice M Huss; Inés Pineda Torra; Bart Staels; Vincent Giguère; Daniel P Kelly
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury.

Authors:  Benita Sjögren; Sergio Parra; Kevin B Atkins; Behirda Karaj; Richard R Neubig
Journal:  J Pharmacol Exp Ther       Date:  2016-03-03       Impact factor: 4.030

9.  Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy.

Authors:  Susan M Dallabrida; Nesreen S Ismail; Elke A Pravda; Emily M Parodi; Renee Dickie; Ellen M Durand; Jean Lai; Flavia Cassiola; Rick A Rogers; Maria A Rupnick
Journal:  FASEB J       Date:  2008-05-23       Impact factor: 5.191

Review 10.  The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure.

Authors:  Ozgur Ogut; Frank V Brozovich
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.